VIROPHARMA INC 4/A SEC Filings

Filed On	Filing
08 Feb 2013	Form 4/A: Brooke Paul A, Director Received 10,000 shares by exercise or conversion ($17.7K)
28 Dec 2012	Form 4/A: Broom Colin Md, VP & Chief Scientific Officer Sold 17,500 shares ($394K)
05 Jan 2012	Form 4/A: Fletcher Robert C., V.P., Business Development Received 1,300 shares by exercise or conversion ($29.9K) · Gave up 1,071 shares to cover exercise price or tax ($29.9K)
04 May 2010	Form 4/A: Baker Brothers Life Sciences Capital (GP), Llc, 10% owner and 2 others Bought 600,619 shares ($7.64M)
04 May 2010	Form 4/A: 14159 capital (GP), Llc, 10% owner and 2 others Bought 16,579 shares ($211K) · Bought 95,686 shares ($1.25M) · Bought 45,112 shares ($576K)
20 Jan 2004	Form 4/A: Glaser Robert, Director Granted 10,000 Non-Qualified Stock Option (right to buy) ($34.2K)
20 Jan 2004	Form 4/A: Dougherty Michael R, Director Granted 30,000 Non-Qualified Stock Option (right to buy) ($103K)
20 Jan 2004	Form 4/A: Claypool William D Md, Director Granted 10,000 Non-Qualified Stock Option (right to buy) ($34.2K)
20 Jan 2004	Form 4/A: Brooke Paul A, Director Granted 10,000 Non-Qualified Stock Option (right to buy) ($34.2K)
20 Jan 2004	Form 4/A: Baldino Frank Jr, Director Granted 10,000 Non-Qualified Stock Option (right to buy) ($34.2K)

Comments